Results 21 to 30 of about 943,237 (313)

SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model

open access: yesFrontiers in Pharmacology, 2017
Intrahepatic cholestasis is a kind of clinical syndrome along with hepatotoxicity which caused by intrahepatic and systemic accumulations of bile acid. There are several crucial generating factors of the pathogenesis of cholestasis, such as inflammation,
Linxi Yu   +11 more
doaj   +1 more source

Is This Drug Screen Really Negative? Special Investigation of Drug Screening in Pediatrics [PDF]

open access: yesThe Journal of Applied Laboratory Medicine, 2017
We report a case of a child with a negative qualitative opioid result on a urine drug screen using our routine cutoff but a positive confirmation for heroin. A 3-month-old male presented to the emergency department after an unexplained episode of hypoxia.
Amy L, Pyle-Eilola   +3 more
openaire   +2 more sources

Application of RNAi to Genomic Drug Target Validation in Schistosomes. [PDF]

open access: yes, 2015
Concerns over the possibility of resistance developing to praziquantel (PZQ), has stimulated efforts to develop new drugs for schistosomiasis. In addition to the development of improved whole organism screens, the success of RNA interference (RNAi) in ...
Bickle, Quentin D   +29 more
core   +1 more source

Prevalence and risk factors of syphilis infection among drug addicts [PDF]

open access: yes, 2005
Background: Recent epidemiological data show an increased trend of official estimates for syphilis infection in the general population. Many of the infected cases remain undetected leaving an underestimation of the true prevalence of syphilis in the ...
Scherbaum, Norbert   +31 more
core   +1 more source

Brevinin-2GHk, a Peptide Derived from the Skin of Fejervarya limnocharis, Inhibits Zika Virus Infection by Disrupting Viral Integrity

open access: yesViruses, 2021
Several years have passed since the Zika virus (ZIKV) pandemic reoccurred in 2015–2016. However, there is still a lack of proved protective vaccines or effective drugs against ZIKV.
Weichen Xiong   +9 more
doaj   +1 more source

Inhibitors of Helicobacter pylori protease HtrA found by "virtual ligand" screening combat bacterial invasion of epithelia [PDF]

open access: yes, 2011
Background: The human pathogen Helicobacter pylori (H. pylori) is a main cause for gastric inflammation and cancer. Increasing bacterial resistance against antibiotics demands for innovative strategies for therapeutic intervention.
Löwer, Martin   +18 more
core   +1 more source

Deoxypodophyllotoxin Induces G2/M Cell Cycle Arrest and Apoptosis in SGC-7901 Cells and Inhibits Tumor Growth in Vivo

open access: yesMolecules, 2015
Deoxypodophyllotoxin (DPT), a natural microtubule destabilizer, was isolated from Anthriscus sylvestris, and a few studies have reported its anti-cancer effect. However, the in vivo antitumor efficacy of DPT is currently indeterminate.
Yu-Rong Wang   +6 more
doaj   +1 more source

Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target [PDF]

open access: yes, 2014
The human pathogen Mycobacterium tuberculosis is the causative agent of pulmonary tuberculosis (TB), a disease with high worldwide mortality rates. Current treatment programs are under significant threat from multi-drug and extensively-drug resistant ...
VijayaShankar Nataraj   +75 more
core   +1 more source

Insoluble Fiber in Barley Leaf Attenuates Hyperuricemic Nephropathy by Modulating Gut Microbiota and Short-Chain Fatty Acids

open access: yesFoods, 2022
Hyperuricemia (HUA), characterized by abnormal serum uric acid (UA) levels, is recognized as an important risk factor for hyperuricemic nephropathy (HN), which is strongly linked to gut microbiota.
Yongmei Li   +8 more
doaj   +1 more source

Screening designs for drug development [PDF]

open access: yesBiostatistics, 2006
We propose drug screening designs based on a Bayesian decision-theoretic approach. The discussion is motivated by screening designs for phase II studies. The proposed screening designs allow consideration of multiple treatments simultaneously. In each period, new treatments can arise and currently considered treatments can be dropped.
David, Rossell   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy